People are buying weight loss drugs online but the cut-price deals may not be what they seem to be, health chiefs warned.

Experts warn that the surge in demand for weight loss injections like Ozempic and Wegovy is unsustainable, with most users ...

We are nearing a point of no return for GLP-1 drugs. More than one in 10 Americans have already taken a GLP-1 agonist, be it ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Ozempic and its counterparts, including Wegovy, Mounjaro and Zepbound, have surged in popularity as a means for weight loss, fueled by celebrity endorsements and slick pharmaceutical marketing.

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.

Pharmacies have warned that the demand for weight loss medication risks going far beyond what is clinically deliverable 🚨 ...

More than half (55%) of adults say they are now drinking less than they were two years ago - a figure that’s likely linked to a reduction in nights out and a preference for staying in.

New research has revealed that people taking weight loss drugs like Wegovy and Mounjaro are increasingly more likely to ...

FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some ...

Weight loss jab users have panicked over going cold turkey after pharmacists warned of potential shortages in the UK due to ...